Reprogramming Synthetic Cells for Targeted Cancer Therapy.

Lim, Boon; Yin, Yutong; Ye, Hua; Cui, Zhanfeng; Papachristodoulou, Antonis; Huang, Wei E

Lim, Boon; Yin, Yutong; Ye, Hua; Cui, Zhanfeng; Papachristodoulou, Antonis; Huang, Wei E.

Afiliación

Lim B; Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ Oxford, U.K.
Yin Y; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, OX3 7DQ Oxford, U.K.
Ye H; Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ Oxford, U.K.
Cui Z; Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ Oxford, U.K.
Papachristodoulou A; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, OX3 7DQ Oxford, U.K.
Huang WE; Department of Engineering Science, University of Oxford, Parks Road, OX1 3PJ Oxford, U.K.

ACS Synth Biol ; 11(3): 1349-1360, 2022 03 18.

Article en En | MEDLINE | ID: mdl-35255684

Asunto(s)

Células Artificiales; Neoplasias; Células CACO-2; Antígeno Carcinoembrionario/genética; Antígeno Carcinoembrionario/metabolismo; Humanos; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Salicilatos; Biología Sintética

Palabras clave

I-CeuI endonuclease; SimCells; bacterial therapy; cancer; catechol; chromosome-free; drug delivery; minicells; synthetic biology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Artificiales / Neoplasias Límite: Humans Idioma: En Revista: ACS Synth Biol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google